Search Results - "Liew, Houng B."

Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial by Kedhi, Elvin, Verdoia, Monica, Suryapranata, Harry, Damen, Sander, Camaro, Cyril, Benit, Edouard, Barbieri, Lucia, Rasoul, Saman, Liew, Houng B., Polad, Jawed, Ahmad, Wan AW, Zambahari, Robaayah, Lalmand, Jacques, van der Schaaf, Renè J., Koh, Tian H., Timmermans, Philippe, Dilling-Boer, Dagmara, Veenstra, Leo F., van’ t Hof, Arnoud WJ, Lee, Stephen WL, Roolvink, Vincent, Ligtenberg, Erik, Postma, Sonja, Kolkman, Evelien JJ, Brouwer, Marc A., Dudek, Dariusz, De Luca, Giuseppe

“…The impact of advanced age on the optimal duration of dual antiplatelet therapy (DAPT) in patients with acute coronary syndrome (ACS) undergoing percutaneous…”
Get full text

Coronary Stenting in High Bleeding Risk Patients With Small Coronary Arteries Followed by One-Month Dual Antiplatelet Therapy: Onyx ONE Clear by Moreno, Raúl, Kandzari, David E., Kirtane, Ajay J., Windecker, Stephan, Latib, Azeem, Kedhi, Elvin, Mehran, Roxana, Price, Matthew J., Simon, Daniel I., Worthley, Stephen G., Spriggs, Douglas, Tolleson, Thaddeus, Nazif, Tamim, Golwala, Harsh, Kander, Nathan H., Liew, Houng B., Sardella, Gennaro, Tamburino, Corrado, Lung, Te-Hsin, Mahoney, Cecile, Stone, Gregg W.

“…Small reference vessel diameters (RVDs) are a predictor of ischemic events after coronary stenting. Among patients at high bleeding risk (HBR) precluding…”
Get full text